Cardiac Amyloid Biorepository
study id #: NCT05521503
condition: Cardiac Amyloidosis
status: Recruiting
purpose:Use samples procured from patients to improve understanding of molecular, cellular, and tissue-level processes produced by cardiac amyloidosis and therapeutic interventions.
results: https://clinicaltrials.gov/ct2/show/results/NCT05521503
last updated: February 22, 2024
-
Combination Therapy Holds Promise for Newly Diagnosed Systemic AL Amyloidosis PatientsUpdated research regarding the ANDROMEDA...
-
Renal amyloidosisAmyloidosis is a rare disease caused by ...
-
Ute HegenbartUte Hegenbart is a Senior Physician and ...
-
Jeremy T. Larsen, MDJeremy T. Larsen is a Hematologist-Oncol...
-
Gastrointestinal Perforation in Light Chain Amyloidosis in the Era of Novel Agent Therapy: A Case Series and Review ...Gastrointestinal (GI) perforation is rem...
-
Webinar Presentation by David Wolinsky on ATTR Cardiac Amyloidosishttps://www.youtube.com/watch?v=JQAcAE9S...
-
Barry Trachtenberg: Advanced Heart Failure Therapies in Cardiac Amyloidosis – ASG Webinar 1.25.24 – 4/9https://www.youtube.com/watch?v=A9g6r1PQ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.